Microalbuminuria and sRAGE in High-Risk Hypertensive Patients Treated with Nifedipine/Telmisartan Combination Treatment: A Substudy of TALENT

Table 1

Baseline characteristics of patients with and without microalbuminuria. Continuous data are reported as mean ± SD or median (interquartile range), categorical data are presented as per group percentages.

Variable	With microalbuminuria; 𝑁=99	Without microalbuminuria; 𝑁=163	𝑃 value
Age, years	60±10	58±10	ns
Males	62%	68%	ns
Diabetes mellitus	59%	61%	ns
Mean 24-h SBP, mmHg	137±5	136±5	ns
Mean 24-h DBP, mmHG	84±5	85±5	ns
Total cholesterol, mmol/L	5.06±0.96	5.14±1.14	ns
HDL cholesterol, mmol/L	1.24±0.31	1.21±031	ns
LDL cholesterol, mmol/L	3.1±0.85	3.15±1.01	ns
Triglycerides, mmol/L	1.74±1.1	1.65±0.95	ns
Body mass index, Kg/m^2	29±3	29±3	ns
Smokers, %	56%	48%	ns
Creatinine, μmol/L	82.2±19.4	82.2±19.4	ns
GFR mL/s/1.73 m^2	1.55±0.38	1.57±0.45	ns
Log-transformed sRAGE	5.12±0.6	5.14±0.6	ns

SBP: systolic blood pressure; DBP: diastolic blood pressure; GFR: glomerular filtration rate.